Skip to main content
. 2013 Jul 24;5(3):901–918. doi: 10.3390/cancers5030901

Figure 1.

Figure 1

Anti-myeloma activity of PHA-767491. KMS-18 (A) and MM1S (B) were treated with different doses of PHA-767491 for 24 h and apoptosis was analysed by flow cytometry using AV staining. Data are presented as mean ± standard deviation of two independent repeats; (C,D) Purified mononuclear cells from two healthy donors were treated with different doses of PHA-767491 for 24 h and apoptosis was analysed by flow cytometry using AV staining. The M in the x axes defines Molarity.